☰

Jill M. Weimer, Ph.D. - Publications

Affiliations: 
2006 University of Rochester, Rochester, NY 
Area:
Neuroscience Biology
Tree Info Grants Similar researchers PubMed Report error

70 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Leppert HG, Anderson JT, Timm KJ, Davoli C, Pratt MA, Booth CD, White KA, Rechtzigel MJ, Meyerink BL, Johnson TB, Brudvig JJ, Weimer JM. Sortilin inhibition treats multiple neurodegenerative lysosomal storage disorders. Biorxiv : the Preprint Server For Biology. PMID 37790379 DOI: 10.1101/2023.09.22.559064  0.783
2023 Centa JL, Stratton MP, Pratt MA, Osterlund Oltmanns JR, Wallace DG, Miller SA, Weimer JM, Hastings ML. Protracted CLN3 Batten disease in mice that genetically model an exon-skipping therapeutic approach. Molecular Therapy. Nucleic Acids. 33: 15-27. PMID 37359347 DOI: 10.1016/j.omtn.2023.05.025  0.34
2023 Swier VJ, White KA, Johnson TB, Wang X, Han J, Pearce DA, Singh R, Drack AV, Pfeifer W, Rogers CS, Brudvig JJ, Weimer JM. A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes. Disease Models & Mechanisms. PMID 37305926 DOI: 10.1242/dmm.050038  0.794
2023 Johnson TB, Brudvig JJ, Likhite S, Pratt MA, White KA, Cain JT, Booth CD, Timm DJ, Davis SS, Meyerink B, Pineda R, Dennys-Rivers C, Kaspar BK, Meyer K, Weimer JM. Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease. Frontiers in Genetics. 14: 1118649. PMID 37035740 DOI: 10.3389/fgene.2023.1118649  0.793
2022 Holmes AD, White KA, Pratt MA, Johnson TB, Likhite S, Meyer K, Weimer JM. Sex-split analysis of pathology and motor-behavioral outcomes in a mouse model of CLN8-Batten disease reveals an increased disease burden and trajectory in female Cln8 mice. Orphanet Journal of Rare Diseases. 17: 411. PMID 36369162 DOI: 10.1186/s13023-022-02564-7  0.339
2022 Brudvig JJ, Swier VJ, Johnson TB, Cain JC, Pratt M, Rechtzigel M, Leppert H, Dang Do AN, Porter FD, Weimer JM. Glycerophosphoinositol is Elevated in Blood Samples From pigs, Mice, and CLN3-Affected Individuals. Biomarker Insights. 17: 11772719221107765. PMID 36212622 DOI: 10.1177/11772719221107765  0.773
2022 Swier VJ, White KA, Johnson TB, Sieren JC, Johnson HJ, Knoernschild K, Wang X, Rohret FA, Rogers CS, Pearce DA, Brudvig JJ, Weimer JM. A Novel Porcine Model of CLN2 Batten Disease that Recapitulates Patient Phenotypes. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 36100791 DOI: 10.1007/s13311-022-01296-7  0.78
2022 Rechtzigel MJ, Meyerink BL, Leppert H, Johnson TB, Cain JT, Ferrandino G, May DG, Roux KJ, Brudvig JJ, Weimer JM. Transmembrane Batten Disease Proteins Interact With a Shared Network of Vesicle Sorting Proteins, Impacting Their Synaptic Enrichment. Frontiers in Neuroscience. 16: 834780. PMID 35692423 DOI: 10.3389/fnins.2022.834780  0.783
2022 Brudvig JJ, Weimer JM. CLN7 gene therapy: hope for an ultra-rare condition. The Journal of Clinical Investigation. 132. PMID 35229731 DOI: 10.1172/JCI157820  0.776
2022 Muthusamy N, Williams TI, O'Toole R, Brudvig JJ, Adler KB, Weimer JM, Muddiman DC, Ghashghaei HT. Phosphorylation-dependent proteome of Marcks in ependyma during aging and behavioral homeostasis in the mouse forebrain. Geroscience. PMID 35075585 DOI: 10.1007/s11357-022-00517-3  0.773
2021 Lu CL, Ortmeier S, Brudvig J, Moretti T, Cain J, Boyadjiev SA, Weimer JM, Kim J. Collagen has a unique SEC24 preference for efficient export from the endoplasmic reticulum. Traffic (Copenhagen, Denmark). PMID 34761479 DOI: 10.1111/tra.12826  0.76
2021 Brudvig JJ, Weimer JM. On the cusp of cures: Breakthroughs in Batten disease research. Current Opinion in Neurobiology. 72: 48-54. PMID 34571324 DOI: 10.1016/j.conb.2021.08.003  0.781
2021 Selvan N, Mehta N, Venkateswaran S, Brignol N, Graziano M, Sheikh MO, McAnany Y, Hung F, Madrid M, Krampetz R, Siano N, Mehta A, Brudvig J, Gotschall R, Weimer JM, et al. Endolysosomal N-glycan processing is critical to attain the most active form of the enzyme acid alpha-glucosidase. The Journal of Biological Chemistry. 100769. PMID 33971197 DOI: 10.1016/j.jbc.2021.100769  0.731
2021 White KA, Nelvagal HR, Poole TA, Lu B, Johnson TB, Davis S, Pratt MA, Brudvig J, Assis AB, Likhite S, Meyer K, Kaspar BK, Cooper JD, Wang S, Weimer JM. Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease mice. Molecular Therapy. Methods & Clinical Development. 20: 497-507. PMID 33665223 DOI: 10.1016/j.omtm.2020.12.014  0.777
2021 Tang C, Han J, Dalvi S, Manian K, Winschel L, Volland S, Soto CA, Galloway CA, Spencer W, Roll M, Milliner C, Bonilha VL, Johnson TB, Latchney L, Weimer JM, et al. A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor-RPE interface. Communications Biology. 4: 161. PMID 33547385 DOI: 10.1038/s42003-021-01682-5  0.311
2020 Johnson TB, White KA, Brudvig JJ, Cain JT, Langin L, Pratt MA, Booth CD, Timm DJ, Davis SS, Meyerink B, Likhite S, Meyer K, Weimer JM. AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 33010819 DOI: 10.1016/j.ymthe.2020.09.033  0.811
2020 Centa JL, Jodelka FM, Hinrich AJ, Johnson TB, Ochaba J, Jackson M, Duelli DM, Weimer JM, Rigo F, Hastings ML. Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease. Nature Medicine. PMID 32719489 DOI: 10.1038/S41591-020-0986-1  0.466
2020 Langin L, Johnson TB, Kovács AD, Pearce DA, Weimer JM. A tailored Cln3 mouse model for testing therapeutic interventions in CLN3 Batten disease. Scientific Reports. 10: 10591. PMID 32601357 DOI: 10.1038/S41598-020-67478-5  0.461
2020 Bajaj L, Sharma J, di Ronza A, Zhang P, Eblimit A, Pal R, Roman D, Collette JR, Booth C, Chang KT, Sifers RN, Jung SY, Weimer JM, Chen R, Schekman RW, et al. A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transfer. The Journal of Clinical Investigation. PMID 32597833 DOI: 10.1172/Jci130955  0.35
2020 Johnson TB, Mechels K, Anderson RH, Cain JT, Sturdevant DA, Braddock S, Pinz H, Wilson MA, Landsverk M, Roux KJ, Weimer JM. Author Correction: Characterization of a recurrent missense mutation in the forkhead DNA-binding domain of FOXP1. Scientific Reports. 10: 6635. PMID 32296074 DOI: 10.1038/S41598-020-62950-8  0.682
2020 Johnson TB, Brudvig JJ, Lehtimäki KK, Cain JT, White KA, Bragge T, Rytkönen J, Huhtala T, Timm D, Vihma M, Puoliväli JT, Poutiainen P, Nurmi A, Weimer JM. A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease. Progress in Neurobiology. 101789. PMID 32198061 DOI: 10.1016/J.Pneurobio.2020.101789  0.798
2020 Uthoff J, Larson J, Sato TS, Hammond E, Schroeder KE, Rohret F, Rogers CS, Quelle DE, Darbro BW, Khanna R, Weimer JM, Meyerholz DK, Sieren JC. Longitudinal phenotype development in a minipig model of neurofibromatosis type 1. Scientific Reports. 10: 5046. PMID 32193437 DOI: 10.1038/S41598-020-61251-4  0.318
2020 Swier VJ, White KA, Meyerholz DK, Chefdeville A, Khanna R, Sieren JC, Quelle DE, Weimer JM. Validating indicators of CNS disorders in a swine model of neurological disease. Plos One. 15: e0228222. PMID 32074109 DOI: 10.1371/Journal.Pone.0228222  0.409
2020 Oksman J, Lehtimäki K, Bragge T, Rytkönen J, Puoliväli J, Poutiainen P, Johnson TB, Cain JT, Davis S, Nurmi A, Weimer J. Principal component analysis (PCA) based data fusion approach for a mouse model of CLN8 Batten disease Molecular Genetics and Metabolism. 129: S119. DOI: 10.1016/J.Ymgme.2019.11.308  0.724
2020 Lehtimäki K, Bragge T, Rytkönen J, Puoliväli J, Poutiainen P, Cerrada-Gimenez M, Kalesnykas G, Johnson TB, Cain JT, Davis S, Nurmi A, Weimer J. Longitudinal characterization of the mouse model of CLN8 Batten disease fine motor performance, retinal degeneration, brain pathology, and metabolic changes Molecular Genetics and Metabolism. 129: S97. DOI: 10.1016/J.Ymgme.2019.11.244  0.732
2019 White KA, Cain JT, Magee H, Yeon SK, Park KD, Khanna R, Weimer JM. Modulation of CRMP2 via ()-Lacosamide shows therapeutic promise but is ultimately ineffective in a mouse model of CLN6-Batten disease. Health Psychology and Behavioral Medicine. 3: NS20190001. PMID 32269836 DOI: 10.1042/NS20190001  0.756
2019 Johnson TB, Langin LM, Zhao J, Weimer JM, Pearce DA, Kovács AD. Changes in motor behavior, neuropathology, and gut microbiota of a Batten disease mouse model following administration of acidified drinking water. Scientific Reports. 9: 14962. PMID 31628420 DOI: 10.1038/S41598-019-51488-Z  0.362
2019 Cain JT, Likhite S, White KA, Timm DJ, Davis SS, Johnson TB, Dennys-Rivers CN, Rinaldi F, Motti D, Corcoran S, Morales P, Pierson C, Hughes SM, Lee SY, Kaspar BK, ... ... Weimer JM, et al. Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten Disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31331814 DOI: 10.1016/J.Ymthe.2019.06.015  0.748
2019 Johnson TB, Cain JT, White KA, Ramirez-Montealegre D, Pearce DA, Weimer JM. Therapeutic landscape for Batten disease: current treatments and future prospects. Nature Reviews. Neurology. PMID 30783219 DOI: 10.1038/S41582-019-0138-8  0.776
2019 Poppens MJ, Cain JT, Johnson TB, White KA, Davis SS, Laufmann R, Kloth AD, Weimer JM. Tracking sex-dependent differences in a mouse model of CLN6-Batten disease. Orphanet Journal of Rare Diseases. 14: 19. PMID 30665444 DOI: 10.1186/S13023-019-0994-8  0.766
2019 Johnson TB, Sturdevant DA, White KA, Drack AV, Bhattarai S, Rogers C, Cooper JD, Pearce DA, Weimer JM. Characterization of a novel porcine model of CLN3-Batten disease Molecular Genetics and Metabolism. 126: S81. DOI: 10.1016/J.Ymgme.2018.12.198  0.482
2019 Cain JT, Johnson TB, White K, Meyerink B, Staton C, Davis S, Sturdevant D, Bragge T, Huhtala T, Brudvig J, Rytkonen J, Lehtimaki K, Nurmi A, Nurmi A, Weimer J. Identifying a biomarker signature for Batten disease Molecular Genetics and Metabolism. 126: S35-S36. DOI: 10.1016/J.Ymgme.2018.12.070  0.78
2018 Johnson TB, Mechels K, Anderson RE, Cain JT, Sturdevant DA, Braddock S, Pinz H, Wilson MA, Landsverk M, Roux KJ, Weimer JM. Characterization of a recurrent missense mutation in the forkhead DNA-binding domain of FOXP1. Scientific Reports. 8: 16161. PMID 30385778 DOI: 10.1038/S41598-018-34437-0  0.71
2018 Madeo M, Colbert PL, Vermeer DW, Lucido CT, Cain JT, Vichaya EG, Grossberg AJ, Muirhead D, Rickel AP, Hong Z, Zhao J, Weimer JM, Spanos WC, Lee JH, Dantzer R, et al. Cancer exosomes induce tumor innervation. Nature Communications. 9: 4284. PMID 30327461 DOI: 10.1038/S41467-018-06640-0  0.665
2018 Brudvig JJ, Cain JT, Sears RM, Schmidt-Grimminger GG, Wittchen ES, Adler KB, Ghashghaei HT, Weimer JM. MARCKS regulates neuritogenesis and interacts with a CDC42 signaling network. Scientific Reports. 8: 13278. PMID 30185885 DOI: 10.1038/S41598-018-31578-0  0.752
2018 Timm D, Cain JT, Geraets RD, White KA, Koh SY, Kielian T, Pearce DA, Hastings ML, Weimer JM. Searching for novel biomarkers using a mouse model of CLN3-Batten disease. Plos One. 13: e0201470. PMID 30086172 DOI: 10.1371/Journal.Pone.0201470  0.772
2018 White KA, Swier VJ, Cain JT, Kohlmeyer JL, Meyerholz DK, Tanas MR, Uthoff J, Hammond E, Li H, Rohret FA, Goeken A, Chan CH, Leidinger MR, Umesalma S, Wallace MR, ... ... Weimer JM, et al. A porcine model of neurofibromatosis type 1 that mimics the human disease. Jci Insight. 3. PMID 29925695 DOI: 10.1172/Jci.Insight.120402  0.712
2018 Brudvig JJ, Cain JT, Schmidt-Grimminger GG, Stumpo DJ, Roux KJ, Blackshear PJ, Weimer JM. MARCKS Is Necessary for Netrin-DCC Signaling and Corpus Callosum Formation. Molecular Neurobiology. PMID 29546593 DOI: 10.1007/S12035-018-0990-3  0.748
2018 Laufmann R, Aegerter C, Meyerink B, Weimer J, Vitiello P. Loss of Thioredoxin-1 in central nervous system neurons results in cerebellar ataxic behavioral deficits Free Radical Biology and Medicine. 128: S133. DOI: 10.1016/J.Freeradbiomed.2018.10.350  0.378
2017 Meyerholz DK, Ofori-Amanfo GK, Leidinger MR, Goeken JA, Khanna R, Sieren JC, Darbro BW, Quelle DE, Weimer JM. Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 22155417729357. PMID 28846462 DOI: 10.1369/0022155417729357  0.307
2017 Beraldi R, Meyerholz DK, Savinov A, Kovács AD, Weimer JM, Dykstra JA, Geraets RD, Pearce DA. Genetic Ataxia Telangiectasia porcine model phenocopies the multisystemic features of the human disease. Biochimica Et Biophysica Acta. PMID 28746835 DOI: 10.1016/J.Bbadis.2017.07.020  0.424
2017 Geraets RD, Langin LM, Cain JT, Parker CM, Beraldi R, Kovacs AD, Weimer JM, Pearce DA. A tailored mouse model of CLN2 disease: A nonsense mutant for testing personalized therapies. Plos One. 12: e0176526. PMID 28464005 DOI: 10.1371/Journal.Pone.0176526  0.766
2017 Cain JT, Kim DI, Quast M, Shivega WG, Patrick RJ, Moser C, Reuter S, Perez M, Myers A, Weimer JM, Roux KJ, Landsverk M. Nonsense pathogenic variants in exon 1 of PHOX2B lead to translational reinitiation in congenital central hypoventilation syndrome. American Journal of Medical Genetics. Part A. PMID 28371199 DOI: 10.1002/Ajmg.A.38162  0.726
2017 Dykstra JA, Facile T, Patrick RJ, Francis KR, Milanovich S, Weimer JM, Kota DJ. Concise Review: Fat and Furious: Harnessing the Full Potential of Adipose-Derived Stromal Vascular Fraction. Stem Cells Translational Medicine. PMID 28186685 DOI: 10.1002/Sctm.16-0337  0.323
2016 Geraets RD, Koh SY, Hastings ML, Kielian T, Pearce DA, Weimer JM. Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis. Orphanet Journal of Rare Diseases. 11: 40. PMID 27083890 DOI: 10.1186/S13023-016-0414-2  0.456
2015 Brudvig JJ, Weimer JM. X MARCKS the spot: myristoylated alanine-rich C kinase substrate in neuronal function and disease. Frontiers in Cellular Neuroscience. 9: 407. PMID 26528135 DOI: 10.3389/Fncel.2015.00407  0.755
2015 Beraldi R, Chan CH, Rogers CS, Kovács AD, Meyerholz DK, Trantzas C, Lambertz AM, Darbro BW, Weber KL, White KA, Rheeden RV, Kruer MC, Dacken BA, Wang XJ, Davis BT, ... ... Weimer JM, et al. A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease. Human Molecular Genetics. PMID 26374845 DOI: 10.1093/Hmg/Ddv356  0.455
2015 Watzlawik JO, Kahoud RJ, O'Toole RJ, White KA, Ogden AR, Painter MM, Wootla B, Papke LM, Denic A, Weimer JM, Carey WA, Rodriguez M. Abbreviated exposure to hypoxia is sufficient to induce CNS dysmyelination, modulate spinal motor neuron composition, and impair motor development in neonatal mice. Plos One. 10: e0128007. PMID 26020269 DOI: 10.1371/Journal.Pone.0128007  0.348
2015 Muthusamy N, Sommerville LJ, Moeser AJ, Stumpo DJ, Sannes P, Adler K, Blackshear PJ, Weimer JM, Ghashghaei HT. MARCKS-dependent mucin clearance and lipid metabolism in ependymal cells are required for maintenance of forebrain homeostasis during aging. Aging Cell. PMID 26010231 DOI: 10.1111/Acel.12354  0.698
2013 Morgan JP, Magee H, Wong A, Nelson T, Koch B, Cooper JD, Weimer JM. A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease. Plos One. 8: e78694. PMID 24223841 DOI: 10.1371/Journal.Pone.0078694  0.45
2012 Khanna R, Wilson SM, Brittain JM, Weimer J, Sultana R, Butterfield A, Hensley K. Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders. Future Neurology. 7: 749-771. PMID 23308041 DOI: 10.2217/Fnl.12.68  0.34
2011 Eom TY, Stanco A, Weimer J, Stabingas K, Sibrack E, Gukassyan V, Cheng J, Anton ES. Direct visualization of microtubules using a genetic tool to analyse radial progenitor-astrocyte continuum in brain. Nature Communications. 2: 446. PMID 21863013 DOI: 10.1038/Ncomms1460  0.751
2009 Moy SS, Ghashghaei HT, Nonneman RJ, Weimer JM, Yokota Y, Lee D, Lai C, Threadgill DW, Anton ES. Deficient NRG1-ERBB signaling alters social approach: relevance to genetic mouse models of schizophrenia. Journal of Neurodevelopmental Disorders. 1: 302-12. PMID 21547722 DOI: 10.1007/S11689-009-9017-8  0.757
2009 Weimer JM, Yokota Y, Stanco A, Stumpo DJ, Blackshear PJ, Anton ES. MARCKS modulates radial progenitor placement, proliferation and organization in the developing cerebral cortex. Development (Cambridge, England). 136: 2965-75. PMID 19666823 DOI: 10.1242/Dev.036616  0.772
2009 Weimer JM, Benedict JW, Getty AL, Pontikis CC, Lim MJ, Cooper JD, Pearce DA. Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis. Brain Research. 1266: 93-107. PMID 19230832 DOI: 10.1016/J.Brainres.2009.02.009  0.417
2008 Weimer JM, Stanco A, Cheng JG, Vargo AC, Voora S, Anton ES. A BAC transgenic mouse model to analyze the function of astroglial SPARCL1 (SC1) in the central nervous system. Glia. 56: 935-41. PMID 18381651 DOI: 10.1002/Glia.20666  0.758
2007 Ghashghaei HT, Weimer JM, Schmid RS, Yokota Y, McCarthy KD, Popko B, Anton ES. Reinduction of ErbB2 in astrocytes promotes radial glial progenitor identity in adult cerebral cortex. Genes & Development. 21: 3258-71. PMID 18079173 DOI: 10.1101/Gad.1580407  0.767
2007 Weimer JM, Benedict JW, Elshatory YM, Short DW, Ramirez-Montealegre D, Ryan DA, Alexander NA, Federoff HJ, Cooper JD, Pearce DA. Alterations in striatal dopamine catabolism precede loss of substantia nigra neurons in a mouse model of juvenile neuronal ceroid lipofuscinosis. Brain Research. 1162: 98-112. PMID 17617387 DOI: 10.1016/J.Brainres.2007.05.018  0.548
2006 Kovács AD, Weimer JM, Pearce DA. Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease. Neurobiology of Disease. 22: 575-85. PMID 16483786 DOI: 10.1016/J.Nbd.2005.12.018  0.423
2006 Weimer JM, Custer AW, Benedict JW, Alexander NA, Kingsley E, Federoff HJ, Cooper JD, Pearce DA. Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons. Neurobiology of Disease. 22: 284-93. PMID 16412658 DOI: 10.1016/J.Nbd.2005.11.008  0.544
2006 Weimer JM, Anton ES. Doubling up on microtubule stabilizers: synergistic functions of doublecortin-like kinase and doublecortin in the developing cerebral cortex. Neuron. 49: 3-4. PMID 16387632 DOI: 10.1016/j.neuron.2005.12.016  0.473
2005 Kwon JM, Rothberg PG, Leman AR, Weimer JM, Mink JW, Pearce DA. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype. Neuroscience Letters. 387: 111-4. PMID 16087292 DOI: 10.1016/J.Neulet.2005.07.023  0.431
2005 Weimer JM, Chattopadhyay S, Custer AW, Pearce DA. Elevation of Hook1 in a disease model of Batten disease does not affect a novel interaction between Ankyrin G and Hook1. Biochemical and Biophysical Research Communications. 330: 1176-81. PMID 15823567 DOI: 10.1016/J.Bbrc.2005.03.103  0.366
2005 Phillips SN, Benedict JW, Weimer JM, Pearce DA. CLN3, the protein associated with batten disease: structure, function and localization. Journal of Neuroscience Research. 79: 573-83. PMID 15657902 DOI: 10.1002/Jnr.20367  0.394
2002 Weimer JM, Kriscenski-Perry E, Elshatory Y, Pearce DA. The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease. Neuromolecular Medicine. 1: 111-24. PMID 12025857 DOI: 10.1385/Nmm:1:2:111  0.484
2000 Sharp JL, Weimer JM, Coleman PD. The change of 4.1N message expression in Alzheimer's disease brain Neurobiology of Aging. 21: 83. DOI: 10.1016/S0197-4580(00)82596-8  0.33
2000 Smith JJ, Weimer JM, Ahmed M, Chow N, Coleman PD. Disregulation of tuberin and P21RAS-GAP in Alzheimer's disease Neurobiology of Aging. 21: 185. DOI: 10.1016/S0197-4580(00)82170-3  0.351
2000 Yao PJ, Weimer JM, Coleman PD. Expression of adaptor protein AP-2 in Alzheimer's disease Neurobiology of Aging. 21: 182. DOI: 10.1016/S0197-4580(00)82158-2  0.347
2000 Weimer JM, Collins L, Chow N, Chang C, Coleman PD. Role of testicular receptor 2 in the pathogenesis of Alzheimer's disease Neurobiology of Aging. 21: 182. DOI: 10.1016/S0197-4580(00)82156-9  0.333
1998 Chow N, Cox C, Callahan LM, Weimer JM, Guo L, Coleman PD. Expression profiles of multiple genes in single neurons of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 95: 9620-5. PMID 9689130 DOI: 10.1073/Pnas.95.16.9620  0.354
Show low-probability matches.